Login / Signup
Qing Xiao
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 2
Top Topics
Cancer Therapy
Long Noncoding Rna
Cell Proliferation
Epithelial Mesenchymal Transition
Top Venues
Cell death & disease
Signal transduction and targeted therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Qing Xiao
,
Jiani Xiao
,
Jiaqi Liu
,
Jiaxin Liu
,
Guang Shu
,
Gang Yin
Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction.
Cell death & disease
13 (3) (2022)
Yimin Li
,
Yaqi Gan
,
Jiaxin Liu
,
Juanni Li
,
Zhengwei Zhou
,
Ruotong Tian
,
Ruizheng Sun
,
Jiaqi Liu
,
Qing Xiao
,
Yuanyuan Li
,
Pengyan Lu
,
Yulong Peng
,
Yuqian Peng
,
Guang Shu
,
Gang Yin
Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer.
Signal transduction and targeted therapy
7 (1) (2022)